Vor to participate in piper sandler 33rd virtual annual healthcare conference

Cambridge, mass., nov. 19, 2021 (globe newswire) -- vor biopharma (nasdaq: vor), a clinical-stage cell and genome engineering company, today announced that dr. robert ang, vor's president and chief executive officer, will be participating at the piper sandler 33rd virtual annual healthcare conference.
VOR Ratings Summary
VOR Quant Ranking